Showing 1–7 of 7 results for author: Initiative, t A D N

Transferring Models Trained on Natural Images to 3D MRI via Position Encoded Slice Models

Authors: Umang Gupta, Tamoghna Chattopadhyay, Nikhil Dhinagar, Paul M. Thompson, Greg Ver Steeg, The Alzheimer's Disease Neuroimaging Initiative

Abstract: Transfer learning has remarkably improved computer vision. These advances also promise improvements in neuroimaging, where training set sizes are often small. However, various difficulties arise in directly applying models pretrained on natural images to radiologic images, such as MRIs. In particular, a mismatch in the input space (2D images vs. 3D MRIs) restricts the direct transfer of models, of… ▽ More Transfer learning has remarkably improved computer vision. These advances also promise improvements in neuroimaging, where training set sizes are often small. However, various difficulties arise in directly applying models pretrained on natural images to radiologic images, such as MRIs. In particular, a mismatch in the input space (2D images vs. 3D MRIs) restricts the direct transfer of models, often forcing us to consider only a few MRI slices as input. To this end, we leverage the 2D-Slice-CNN architecture of Gupta et al. (2021), which embeds all the MRI slices with 2D encoders (neural networks that take 2D image input) and combines them via permutation-invariant layers. With the insight that the pretrained model can serve as the 2D encoder, we initialize the 2D encoder with ImageNet pretrained weights that outperform those initialized and trained from scratch on two neuroimaging tasks -- brain age prediction on the UK Biobank dataset and Alzheimer's disease detection on the ADNI dataset. Further, we improve the modeling capabilities of 2D-Slice models by incorporating spatial information through position embeddings, which can improve the performance in some cases. △ Less

Submitted 2 March, 2023; originally announced March 2023.

Comments: To appear at IEEE International Symposium on Biomedical Imaging 2023 (ISBI 2023). Code is available at https://github.com/umgupta/2d-slice-set-networks

Predicting Time-to-conversion for Dementia of Alzheimer's Type using Multi-modal Deep Survival Analysis

Authors: Ghazal Mirabnahrazam, Da Ma, Cédric Beaulac, Sieun Lee, Karteek Popuri, Hyunwoo Lee, Jiguo Cao, James E Galvin, Lei Wang, Mirza Faisal Beg, the Alzheimer's Disease Neuroimaging Initiative

Abstract: Dementia of Alzheimer's Type (DAT) is a complex disorder influenced by numerous factors, but it is unclear how each factor contributes to disease progression. An in-depth examination of these factors may yield an accurate estimate of time-to-conversion to DAT for patients at various disease stages. We used 401 subjects with 63 features from MRI, genetic, and CDC (Cognitive tests, Demographic, and… ▽ More Dementia of Alzheimer's Type (DAT) is a complex disorder influenced by numerous factors, but it is unclear how each factor contributes to disease progression. An in-depth examination of these factors may yield an accurate estimate of time-to-conversion to DAT for patients at various disease stages. We used 401 subjects with 63 features from MRI, genetic, and CDC (Cognitive tests, Demographic, and CSF) data modalities in the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. We used a deep learning-based survival analysis model that extends the classic Cox regression model to predict time-to-conversion to DAT. Our findings showed that genetic features contributed the least to survival analysis, while CDC features contributed the most. Combining MRI and genetic features improved survival prediction over using either modality alone, but adding CDC to any combination of features only worked as well as using only CDC features. Consequently, our study demonstrated that using the current clinical procedure, which includes gathering cognitive test results, can outperform survival analysis results produced using costly genetic or CSF data. △ Less

Submitted 2 May, 2022; originally announced May 2022.

Journal ref: Neurobiology of Aging, 121, (2023), 139-156

MRI-based Multi-task Decoupling Learning for Alzheimer's Disease Detection and MMSE Score Prediction: A Multi-site Validation

Authors: Xu Tian, ** Liu, Hulin Kuang, Yu Sheng, Jianxin Wang, The Alzheimer's Disease Neuroimaging Initiative

Abstract: Accurately detecting Alzheimer's disease (AD) and predicting mini-mental state examination (MMSE) score are important tasks in elderly health by magnetic resonance imaging (MRI). Most of the previous methods on these two tasks are based on single-task learning and rarely consider the correlation between them. Since the MMSE score, which is an important basis for AD diagnosis, can also reflect the… ▽ More Accurately detecting Alzheimer's disease (AD) and predicting mini-mental state examination (MMSE) score are important tasks in elderly health by magnetic resonance imaging (MRI). Most of the previous methods on these two tasks are based on single-task learning and rarely consider the correlation between them. Since the MMSE score, which is an important basis for AD diagnosis, can also reflect the progress of cognitive impairment, some studies have begun to apply multi-task learning methods to these two tasks. However, how to exploit feature correlation remains a challenging problem for these methods. To comprehensively address this challenge, we propose a MRI-based multi-task decoupled learning method for AD detection and MMSE score prediction. First, a multi-task learning network is proposed to implement AD detection and MMSE score prediction, which exploits feature correlation by adding three multi-task interaction layers between the backbones of the two tasks. Each multi-task interaction layer contains two feature decoupling modules and one feature interaction module. Furthermore, to enhance the generalization between tasks of the features selected by the feature decoupling module, we propose the feature consistency loss constrained feature decoupling module. Finally, in order to exploit the specific distribution information of MMSE score in different groups, a distribution loss is proposed to further enhance the model performance. We evaluate our proposed method on multi-site datasets. Experimental results show that our proposed multi-task decoupled representation learning method achieves good performance, outperforming single-task learning and other existing state-of-the-art methods. △ Less

Submitted 7 July, 2023; v1 submitted 2 April, 2022; originally announced April 2022.

Comments: There are some misstatements in the related work section of the paper. In the methods section, there are also errors in the description of some modules

Machine Learning Based Multimodal Neuroimaging Genomics Dementia Score for Predicting Future Conversion to Alzheimer's Disease

Authors: Ghazal Mirabnahrazam, Da Ma, Sieun Lee, Karteek Popuri, Hyunwoo Lee, Jiguo Cao, Lei Wang, James E Galvin, Mirza Faisal Beg, the Alzheimer's Disease Neuroimaging Initiative

Abstract: Background: The increasing availability of databases containing both magnetic resonance imaging (MRI) and genetic data allows researchers to utilize multimodal data to better understand the characteristics of dementia of Alzheimer's type (DAT). Objective: The goal of this study was to develop and analyze novel biomarkers that can help predict the development and progression of DAT. Methods: We use… ▽ More Background: The increasing availability of databases containing both magnetic resonance imaging (MRI) and genetic data allows researchers to utilize multimodal data to better understand the characteristics of dementia of Alzheimer's type (DAT). Objective: The goal of this study was to develop and analyze novel biomarkers that can help predict the development and progression of DAT. Methods: We used feature selection and ensemble learning classifier to develop an image/genotype-based DAT score that represents a subject's likelihood of develo** DAT in the future. Three feature types were used: MRI only, genetic only, and combined multimodal data. We used a novel data stratification method to better represent different stages of DAT. Using a pre-defined 0.5 threshold on DAT scores, we predicted whether or not a subject would develop DAT in the future. Results: Our results on Alzheimer's Disease Neuroimaging Initiative (ADNI) database showed that dementia scores using genetic data could better predict future DAT progression for currently normal control subjects (Accuracy=0.857) compared to MRI (Accuracy=0.143), while MRI can better characterize subjects with stable mild cognitive impairment (Accuracy=0.614) compared to genetics (Accuracy=0.356). Combining MRI and genetic data showed improved classification performance in the remaining stratified groups. Conclusion: MRI and genetic data can contribute to DAT prediction in different ways. MRI data reflects anatomical changes in the brain, while genetic data can detect the risk of DAT progression prior to the symptomatic onset. Combining information from multimodal data in the right way can improve prediction performance. △ Less

Submitted 10 March, 2022; originally announced March 2022.

Journal ref: J Alzheimers Dis 1 Jan. (2022) 1-21

Diagnosis of Alzheimer's Disease via Multi-modality 3D Convolutional Neural Network

Authors: Yechong Huang, Jiahang Xu, Yuncheng Zhou, Tong Tong, Xiahai Zhuang, the Alzheimer's Disease Neuroimaging Initiative

Abstract: Alzheimer's Disease (AD) is one of the most concerned neurodegenerative diseases. In the last decade, studies on AD diagnosis attached great significance to artificial intelligence (AI)-based diagnostic algorithms. Among the diverse modality imaging data, T1-weighted MRI and 18F-FDGPET are widely researched for this task. In this paper, we propose a novel convolutional neural network (CNN) to fuse… ▽ More Alzheimer's Disease (AD) is one of the most concerned neurodegenerative diseases. In the last decade, studies on AD diagnosis attached great significance to artificial intelligence (AI)-based diagnostic algorithms. Among the diverse modality imaging data, T1-weighted MRI and 18F-FDGPET are widely researched for this task. In this paper, we propose a novel convolutional neural network (CNN) to fuse the multi-modality information including T1-MRI and FDG-PDT images around the hippocampal area for the diagnosis of AD. Different from the traditional machine learning algorithms, this method does not require manually extracted features, and utilizes the stateof-art 3D image-processing CNNs to learn features for the diagnosis and prognosis of AD. To validate the performance of the proposed network, we trained the classifier with paired T1-MRI and FDG-PET images using the ADNI datasets, including 731 Normal (NL) subjects, 647 AD subjects, 441 stable MCI (sMCI) subjects and 326 progressive MCI (pMCI) subjects. We obtained the maximal accuracies of 90.10% for NL/AD task, 87.46% for NL/pMCI task, and 76.90% for sMCI/pMCI task. The proposed framework yields comparative results against state-of-the-art approaches. Moreover, the experimental results have demonstrated that (1) segmentation is not a prerequisite by using CNN, (2) the hippocampal area provides enough information to give a reference to AD diagnosis. Keywords: Alzheimer's Disease, Multi-modality, Image Classification, CNN, Deep Learning, Hippocampal △ Less

Submitted 26 February, 2019; originally announced February 2019.

Comments: 21 pages, 5 figures, 9 tables

Journal ref: https://www.frontiersin.org/articles/10.3389/fnins.2019.00509/full

Neuroimaging Modality Fusion in Alzheimer's Classification Using Convolutional Neural Networks

Authors: Arjun Punjabi, Adam Martersteck, Yanran Wang, Todd B. Parrish, Aggelos K. Katsaggelos, the Alzheimer's Disease Neuroimaging Initiative

Abstract: Automated methods for Alzheimer's disease (AD) classification have the potential for great clinical benefits and may provide insight for combating the disease. Machine learning, and more specifically deep neural networks, have been shown to have great efficacy in this domain. These algorithms often use neurological imaging data such as MRI and PET, but a comprehensive and balanced comparison of th… ▽ More Automated methods for Alzheimer's disease (AD) classification have the potential for great clinical benefits and may provide insight for combating the disease. Machine learning, and more specifically deep neural networks, have been shown to have great efficacy in this domain. These algorithms often use neurological imaging data such as MRI and PET, but a comprehensive and balanced comparison of these modalities has not been performed. In order to accurately determine the relative strength of each imaging variant, this work performs a comparison study in the context of Alzheimer's dementia classification using the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. Furthermore, this work analyzes the benefits of using both modalities in a fusion setting and discusses how these data types may be leveraged in future AD studies using deep learning. △ Less

Submitted 12 November, 2018; originally announced November 2018.

Development and validation of a novel dementia of Alzheimer's type (DAT) score based on metabolism FDG-PET imaging

Authors: Karteek Popuri, Rakesh Balachandar, Kathryn Alpert, Donghuan Lu, Mahadev Bhalla, Ian Mackenzie, Robin Ging-Yuek Hsiung, Lei Wang, Mirza Faisal Beg, the Alzhemier's Disease Neuroimaging Initiative

Abstract: Fluorodeoxyglucose positron emission tomography (FDG-PET) imaging based 3D topographic brain glucose metabolism patterns from normal controls (NC) and individuals with dementia of Alzheimer's type (DAT) are used to train a novel multi-scale ensemble classification model. This ensemble model outputs a FDG-PET DAT score (FPDS) between 0 and 1 denoting the probability of a subject to be clinically di… ▽ More Fluorodeoxyglucose positron emission tomography (FDG-PET) imaging based 3D topographic brain glucose metabolism patterns from normal controls (NC) and individuals with dementia of Alzheimer's type (DAT) are used to train a novel multi-scale ensemble classification model. This ensemble model outputs a FDG-PET DAT score (FPDS) between 0 and 1 denoting the probability of a subject to be clinically diagnosed with DAT based on their metabolism profile. A novel 7 group image stratification scheme is devised that groups images not only based on their associated clinical diagnosis but also on past and future trajectories of the clinical diagnoses, yielding a more continuous representation of the different stages of DAT spectrum that mimics a real-world clinical setting. The potential for using FPDS as a DAT biomarker was validated on a large number of FDG-PET images (N=2984) obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database taken across the proposed stratification, and a good classification AUC (area under the curve) of 0.78 was achieved in distinguishing between images belonging to subjects on a DAT trajectory and those images taken from subjects not progressing to a DAT diagnosis. Further, the FPDS biomarker achieved state-of-the-art performance on the mild cognitive impairment (MCI) to DAT conversion prediction task with an AUC of 0.81, 0.80, 0.77 for the 2, 3, 5 years to conversion windows respectively. △ Less

Submitted 2 November, 2017; originally announced November 2017.